These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24889603)

  • 21. A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C).
    Li N; Liu CF; Zhang W; Rao GW
    Curr Med Chem; 2023 Nov; ():. PubMed ID: 37936461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GTP-Dependent K-Ras Dimerization.
    Muratcioglu S; Chavan TS; Freed BC; Jang H; Khavrutskii L; Freed RN; Dyba MA; Stefanisko K; Tarasov SG; Gursoy A; Keskin O; Tarasova NI; Gaponenko V; Nussinov R
    Structure; 2015 Jul; 23(7):1325-35. PubMed ID: 26051715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and structural insights into RAS effector proteins.
    Mozzarelli AM; Simanshu DK; Castel P
    Mol Cell; 2024 Aug; 84(15):2807-2821. PubMed ID: 39025071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic insights into the effect of phosphorylation on Ras conformational dynamics and its interactions with cell signaling proteins.
    Wang Y; Ji D; Lei C; Chen Y; Qiu Y; Li X; Li M; Ni D; Pu J; Zhang J; Fu Q; Liu Y; Lu S
    Comput Struct Biotechnol J; 2021; 19():1184-1199. PubMed ID: 33680360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket.
    Wallon L; Khan I; Teng KW; Koide A; Zuberi M; Li J; Ketavarapu G; Traaseth NJ; O'Bryan JP; Koide S
    Proc Natl Acad Sci U S A; 2022 Oct; 119(43):e2204481119. PubMed ID: 36252024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.
    Lu S; Jang H; Gu S; Zhang J; Nussinov R
    Chem Soc Rev; 2016 Sep; 45(18):4929-52. PubMed ID: 27396271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.
    Zhang Z; Shokat KM
    Angew Chem Int Ed Engl; 2019 Nov; 58(45):16314-16319. PubMed ID: 31557383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malolactone strikes: K-Ras-G12D's Achilles' heel.
    Adamopoulos C; Papavassiliou KA; Papavassiliou AG
    Trends Pharmacol Sci; 2024 Jun; 45(6):472-474. PubMed ID: 38653668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric binding sites in Rab11 for potential drug candidates.
    Kumar AP; Lukman S
    PLoS One; 2018; 13(6):e0198632. PubMed ID: 29874286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the Significance of Mg
    Tagad A; Patwari GN
    J Phys Chem B; 2024 Feb; 128(7):1618-1626. PubMed ID: 38351706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic targeting of RAS: New hope for drugging the "undruggable".
    Khan I; Rhett JM; O'Bryan JP
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118570. PubMed ID: 31678118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalent Targeting of Ras G12C by Rationally Designed Peptidomimetics.
    Yoo DY; Hauser AD; Joy ST; Bar-Sagi D; Arora PS
    ACS Chem Biol; 2020 Jun; 15(6):1604-1612. PubMed ID: 32378881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras.
    Vatansever S; Erman B; Gümüş ZH
    Comput Struct Biotechnol J; 2020; 18():1000-1011. PubMed ID: 32373288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding hotspots on K-ras: consensus ligand binding sites and other reactive regions from probe-based molecular dynamics analysis.
    Prakash P; Hancock JF; Gorfe AA
    Proteins; 2015 May; 83(5):898-909. PubMed ID: 25740554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Pressure Promotes Binding of the Allosteric Inhibitor Zn
    Girard E; Lopes P; Spoerner M; Dhaussy AC; Prangé T; Kalbitzer HR; Colloc'h N
    Chemistry; 2024 Jun; 30(35):e202400304. PubMed ID: 38647362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.
    Morgan HP; Walsh MJ; Blackburn EA; Wear MA; Boxer MB; Shen M; Veith H; McNae IW; Nowicki MW; Michels PA; Auld DS; Fothergill-Gilmore LA; Walkinshaw MD
    Biochem J; 2012 Nov; 448(1):67-72. PubMed ID: 22906073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strain-release alkylation of Asp12 enables mutant selective targeting of K-Ras-G12D.
    Zheng Q; Zhang Z; Guiley KZ; Shokat KM
    Nat Chem Biol; 2024 Sep; 20(9):1114-1122. PubMed ID: 38443470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry.
    Mehaffey MR; Schardon CL; Novelli ET; Cammarata MB; Webb LJ; Fast W; Brodbelt JS
    Chem Sci; 2019 Sep; 10(34):8025-8034. PubMed ID: 31853358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct Targeting of the Ras GTPase Superfamily Through Structure- Based Design.
    Zhao W; Jamshidiha M; Lanyon-Hogg T; Recchi C; Cota E; Tate EW
    Curr Top Med Chem; 2017; 17(1):16-29. PubMed ID: 27530972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Top-Down Proteomic Assay to Evaluate KRAS4B-Compound Engagement.
    D'Ippolito RA; Rabara D; Blanco MA; Alberico E; Drew MR; Ramakrishnan N; Sontan D; Widmeyer SRT; Scheidemantle GM; Messing S; Turner D; Arkin M; Maciag AE; Stephen AG; Esposito D; McCormick F; Nissley DV; DeHart CJ
    Anal Chem; 2024 Apr; 96(13):5223-5231. PubMed ID: 38498381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.